Sun Pharmaceuticals
Sun Pharma Halol unit gets 3 adverse notices from US FDA: shares rise
24 Feb 2018
Although the strictures will impact Sun Pharmaceutical’s US business, the bourses took a positive view with the company’s shares actually rising, as the number of observations has come from the earlier nine to just three
Sun Pharma Q2 net surges 117% to Rs2,235 cr
10 Nov 2016
